Anticoagulation in Atrial Fibrillation Associated with Mitral Stenosis.
da Silva RMFL.
Cardiovasc Hematol Agents Med Chem. 2022;20(3):172-174. doi: 10.2174/1871525720666220321120944.
PMID:35319395
Management of atrial fibrillation in patients with rheumatic mitral stenosis.
Iung B, Leenhardt A, Extramiana F.
Heart. 2018 Jul;104(13):1062-1068. doi: 10.1136/heartjnl-2017-311425. Epub 2018 Feb 16.
PMID:29453328
Mitral valve geometry in paediatric rheumatic mitral regurgitation.
Yeong M, Silbery M, Finucane K, Wilson NJ, Gentles TL.
Pediatr Cardiol. 2015 Apr;36(4):827-34. doi: 10.1007/s00246-014-1085-1. Epub 2015 Jan 6.
PMID:25560735
Identification of Distinct Subgroups in Moderately Severe Rheumatic Mitral Stenosis Using Data-Driven Phenotyping of Longitudinal Hemodynamic Progression.
Ko KY, Cho I, Kim S, Seong Y, Kim DY, Seo JW, You SC, Shim CY, Hong GR, Ha JW.
J Am Heart Assoc. 2022 Aug 2;11(15):e026375. doi: 10.1161/JAHA.121.026375. Epub 2022 Jul 29.
PMID:35904199
Effectiveness of Percutaneous Balloon Mitral Valvuloplasty for Rheumatic Mitral Stenosis with Mild to Severe Mitral Regurgitation.
Lu L, Hong L, Fang J, Chen L.
Biomed Res Int. 2016;2016:3298343. doi: 10.1155/2016/3298343. Epub 2016 Feb 29.
PMID:27034933
Long-term outcomes of radiofrequency catheter ablation for atrial fibrillation in rheumatic heart disease patients with mild mitral stenosis.